Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mesorectal lymph node dissection: is it beneficial?

W Hohenberger1, C H Schick, J Göhl

  • 1Department of Surgery, University of Erlangen-Nuremberg, Chirurgische Universitätsklinik, Erlangen, Germany.

Langenbeck'S Archives of Surgery
|January 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lymph node mapping-based optimal bowel-resection margin and central radicality in colon cancer surgery: an international, prospective, observational cohort study.

ESMO gastrointestinal oncology·2026
Same author

Defining Standard Data Reporting in Pelvic Exenterations for Non-Rectal Cancers: A Systematic Review of Current Data Reporting.

Cancers·2025
Same author

The Mesentery-Past, Present, and Future.

Clinics in colon and rectal surgery·2022
Same author

Oncological outcome after hyperthermic isolated limb perfusion for primarily unresectable versus locally recurrent soft tissue sarcoma of extremities.

Surgical oncology·2020
Same author

Author response to: Comment on: Prognosis of patients with colonic carcinoma before, during and after implementation of complete mesocolic excision.

The British journal of surgery·2020
Same author

Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Complete mesorectal excision significantly reduces local recurrence rates in rectal cancer surgery. This technique improves long-term survival by preventing cancer spread, especially in advanced stages.

Area of Science:

  • Surgical Oncology
  • Gastrointestinal Surgery
  • Rectal Cancer Management

Background:

  • Local recurrence and distant metastases are key factors in rectal cancer prognosis.
  • Surgical technique is crucial for preventing local recurrence, a major prognostic determinant.
  • Mesorectal excision (ME) was developed to address local recurrence by removing the rectum with surrounding tissues.

Purpose of the Study:

  • To evaluate the impact of mesorectal excision on local recurrence rates and long-term survival in rectal cancer.
  • To analyze factors influencing local recurrence rates after rectal cancer resection.
  • To demonstrate the oncological benefits of ME in rectal cancer surgery.

Main Methods:

  • Retrospective analysis of patient data focusing on surgical techniques and outcomes.

Related Experiment Videos

  • Comparison of local recurrence rates and survival before and after the implementation of ME.
  • Correlation of local recurrence rates with tumor characteristics (depth, lymph node status, grade, location).

    • Main Results:

    • The implementation of ME significantly reduced local recurrence rates from 39.4% to 4.1%.
    • Five-year survival rates improved from 23% (with local recurrence) to 85% (without local recurrence).
    • Local recurrence rates were influenced by tumor infiltration depth, lymph node status, grade, and location, with ME mitigating these effects.

    Conclusions:

    • Mesorectal excision is a highly effective surgical technique for reducing local recurrence in rectal cancer.
    • ME offers significant oncological benefits and improves long-term survival for rectal cancer patients.
    • Total mesorectal excision is recommended for deeper rectal carcinomas to maximize oncological safety.